Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Alx Oncology Holdings Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 87 | 1 | 85 | −1 |
| Shares | 41.1M | 164.8K | 34.8M | −6.10M (−14.9%) |
| Value | $68.5M | $275.2K | $21.7M | −$46.6M (−68.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 271,197 | $168.1K | 0.00% |
| Nuveen, LLC | 164,790 | $102.7K | 0.00% |
| Invesco Ltd. | 73,836 | $46.0K | 0.00% |
| Kazazian Asset Management, LLC | 19,000 | $11.8K | 0.01% |
| Renaissance Technologies LLC | 14,299 | $8.91K | 0.00% |
| Mercer Global Advisors Inc | 10,077 | $6.28K | 0.00% |
| EverSource Wealth Advisors, LLC | 530 | $330 | 0.00% |
| Advisor Group Holdings, Inc. | 100 | $62 | 0.00% |
Sold out (9)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Diadema Partners LP | 197,680 | $330.1K |
| Bridgeway Capital Management, LLC | 75,000 | $125.3K |
| Cubist Systematic Strategies, LLC | 32,021 | $53.5K |
| Dimensional Fund Advisors LP | 26,233 | $43.8K |
| Jane Street Group, LLC | 20,454 | $34.2K |
| Abel Hall, LLC | 10,406 | $17.4K |
| Massmutual Trust Co FSB | 1,270 | $2.12K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 237 | $396 |
| Russell Investments Group, Ltd. | 228 | $381 |
Not filed for Q1 2025 yet (1)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 164,790 | $275.2K |